跳至主要内容
临床试验/NCT02400489
NCT02400489已完成不适用

Clinical Study to Evaluate the Performance of Perimount Heart Valve in Chinese Patients

Edwards Lifesciences3 个研究点 分布在 1 个国家目标入组 265 人开始时间: 2014年9月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
265
试验地点
3
主要终点
Twice echocardiography to evaluate the performance of heart valve

研究概览

简要总结

To recruit patients who implanted with Perimount Heart Valve (Type Number: 6900PTFX or 2800TFX) from three hospitals in China.

To track the patients'situations during one year after surgery and to collect the relevant clinical data.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients implanted with Perimount 6900PTFX after 2012-11-19 or with Perimount 2800TFX after 2013-8-20
  • Patients sign the Inform Consent Form (ICF) and agree to join the study

排除标准

  • Don't have any specific exclusion criteria.

结局指标

主要结局

Twice echocardiography to evaluate the performance of heart valve

时间窗: Compare the 1st echocardiography at average 6 months after surgery and 2nd echocardiography at 12 months after surgery

subjects need to do the echocardiography in two follow up visits

The recovery status of patients after surgery

时间窗: The subjects will be followed for the duration of one year after surgery

次要结局

未报告次要终点

研究者

发起方
Edwards Lifesciences
申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验